Komori
Earnings presentation materials5571Excite Holdings Co.,Ltd.Information and Communications, Services and Others

Financial Results Briefing Materials for the Second Quarter of the Fiscal Year Ending March 2027

In the second quarter of the fiscal year ending March 2027, revenue declined due to restrained advertising investment by ONE MEDICAL. However, operating profit and net income increased substantially due to improvements in the media services business, the SaaS and DX businesses turning profitable, and reduced losses in the medical business. The full-year forecast was left unchanged, and progress in operating profit and net income was described as exceeding expectations.

Worth reading
84Important
Scored from 4 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
501.1
Year-on-year growth in operating profit (standalone 2Q, %)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings presentation materialsSecond quarter of the fiscal year ending March 20278 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥5,113 million-0.2%
Operating profit¥280 million+186.3%
Ordinary income¥295 million+211.6%
Net income¥311 million
Gross Profit Margin55.7%
Operating profit margin5.5%
Results for the three months of the current quarter
Net Sales
¥2,468 million-4.0%
Operating profit
¥177 million+501.1%
Ordinary income
¥204 million+375.3%
Profit attributable to owners of parent for the quarter
¥218 million+1,948.7%
Full-year earnings forecast
Net Sales
¥12,000 million
EBITDA
¥1,200 million
Operating profit
¥610 million
Ordinary income
¥560 million
Profit attributable to owners of the parent
¥350 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales42.6%
EBITDA50.8%
Operating profit46.0%
Ordinary income52.8%
Profit attributable to owners of the parent88.9%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue was slightly behind expectations, operating profit was ahead of expectations, and net income attributable to owners of the parent was substantially ahead of expectations.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Restrained advertising investment by ONE MEDICAL
    DetailsLower revenue and reduced losses in the medical business
  • Improved profitability in media services
    DetailsHigher profit in the platform business
  • Return to profitability of the SaaS business
    DetailsImproved profitability in the SaaS and DX businesses
  • Higher non-operating income and lower tax expenses
    DetailsImproved net income
  • The ¥101 million extraordinary loss recorded in the previous fiscal year was eliminated
    DetailsImproved net income
New initiatives
  • Expansion of AI-assisted manga content production
  • Expand the number of new AI-produced series to 12
  • Position AI as a growth area in research and development, and expand production volume and revenue
  • Restrain advertising investment in ONE MEDICAL and reinvest in areas with high investment efficiency after improving unit economics
Key KPIsA metric the company considers important as a management benchmark.
  • Number of 10G line contracts6,001 projects
    Year on year against the same period last yearApproximately 15 times year on year
  • Average monthly page views for Media Services
    Year on year against the same period last yearUp 12.5% year on year
  • Number of broadband paying subscribers65,448 people
    Year on year against the same period last yearUp 7.5% year on year
  • SaaS business ARR¥660 million
    Year on year against the same period last yearUp 34.8%
  • Percentage of revenue from AI-produced content9.2%
    Year on year against the same period last yearUp 3.7 percentage points from 5.5% in the previous quarter
  • Number of counselling service consultations
    Year on year against the same period last yearDown 0.9% year on year
  • Repeat customer ratio75.3%
    Year on year against the same period last yearUp from 69.2% in the previous fiscal year
Segment results
  • Medical Business
    Net Sales¥387 million (down 36.8% year on year)
    Operating profit¥50 million loss (¥36 million improvement year on year)
  • Platform Business
    Net Sales¥905 million (up 7.1% year on year)
    Operating profit¥211 million (up 69.3% year on year)
  • Broadband business
    Net Sales¥946 million (up 5.2% year on year)
    Operating profit¥126 million (down 3.0% year on year)
  • SaaS and DX Business
    Net Sales¥229 million (up 7.4% year on year)
    Operating profit¥15 million (up ¥44 million year on year)
Financial targets
The equity ratio was 34.8%, up 2.5 percentage points from the end of the previous fiscal year. The target value was Not disclosed.
Market Size / Share
  • Domestic aesthetic medical market size: approximately ¥644 billion (up 2.1% year on year)
  • Domestic online medical consultation market size: ¥124.8 billion; forecast to reach ¥173.5 billion in 2030 and ¥259.1 billion in 2040
  • 2025 internet advertising expenditure: ¥4.0459 trillion, 110.8% of the previous year and 50.2% of total advertising expenditure
Number of employees
Number of Employees236 people
Reference dateEnd of September 2026
Contents of this document
ItemDetails
Document typeEarnings presentation materials
Fiscal Period CoveredSecond quarter of the fiscal year ending March 2027
Net Sales¥5,113 million (YoY -0.2%)
Operating profit¥280 million (YoY +186.3%)
Ordinary income¥295 million (YoY +211.6%)
Net income¥311 million
Gross Profit Margin55.7%
Operating profit margin5.5%
Results for the three months of the current quarterNet Sales ¥2,468 million (YoY -4.0%) / Operating profit ¥177 million (YoY +501.1%) / Ordinary income ¥204 million (YoY +375.3%) / Profit attributable to owners of parent for the quarter ¥218 million (YoY +1,948.7%)
Full-year earnings forecastNet Sales ¥12,000 million / EBITDA ¥1,200 million / Operating profit ¥610 million / Ordinary income ¥560 million / Profit attributable to owners of the parent ¥350 million
Progress against full-year forecastNet Sales 42.6% / EBITDA 50.8% / Operating profit 46.0% / Ordinary income 52.8% / Profit attributable to owners of the parent 88.9%
Self-assessment against the planRevenue was slightly behind expectations, operating profit was ahead of expectations, and net income attributable to owners of the parent was substantially ahead of expectations.
Segment resultsSegment Medical Business / Net Sales ¥387 million (down 36.8% year on year) / Operating profit ¥50 million loss (¥36 million improvement year on year), Segment Platform Business / Net Sales ¥905 million (up 7.1% year on year) / Operating profit ¥211 million (up 69.3% year on year), Segment Broadband business / Net Sales ¥946 million (up 5.2% year on year) / Operating profit ¥126 million (down 3.0% year on year), Segment SaaS and DX Business / Net Sales ¥229 million (up 7.4% year on year) / Operating profit ¥15 million (up ¥44 million year on year)
Breakdown of Factors Affecting the ChangeFactors Restrained advertising investment by ONE MEDICAL / Details Lower revenue and reduced losses in the medical business, Factors Improved profitability in media services / Details Higher profit in the platform business, Factors Return to profitability of the SaaS business / Details Improved profitability in the SaaS and DX businesses, Factors Higher non-operating income and lower tax expenses / Details Improved net income, Factors The ¥101 million extraordinary loss recorded in the previous fiscal year was eliminated / Details Improved net income
Key KPIsIndicator name Number of 10G line contracts / Value 6,001 projects / Year on year against the same period last year Approximately 15 times year on year, Indicator name Average monthly page views for Media Services / Value Not disclosed / Year on year against the same period last year Up 12.5% year on year, Indicator name Number of broadband paying subscribers / Value 65,448 people / Year on year against the same period last year Up 7.5% year on year, Indicator name SaaS business ARR / Value ¥660 million / Year on year against the same period last year Up 34.8%, Indicator name Percentage of revenue from AI-produced content / Value 9.2% / Year on year against the same period last year Up 3.7 percentage points from 5.5% in the previous quarter, Indicator name Number of counselling service consultations / Value Not disclosed / Year on year against the same period last year Down 0.9% year on year, Indicator name Repeat customer ratio / Value 75.3% / Year on year against the same period last year Up from 69.2% in the previous fiscal year
Number of employeesNumber of Employees 236 people / Reference date End of September 2026 / Changes during the period and hiring plan Not disclosed
Financial targetsThe equity ratio was 34.8%, up 2.5 percentage points from the end of the previous fiscal year. The target value was Not disclosed.
Market Size / ShareDomestic aesthetic medical market size: approximately ¥644 billion (up 2.1% year on year), Domestic online medical consultation market size: ¥124.8 billion; forecast to reach ¥173.5 billion in 2030 and ¥259.1 billion in 2040, 2025 internet advertising expenditure: ¥4.0459 trillion, 110.8% of the previous year and 50.2% of total advertising expenditure
New initiativesExpansion of AI-assisted manga content production, Expand the number of new AI-produced series to 12, Position AI as a growth area in research and development, and expand production volume and revenue, Restrain advertising investment in ONE MEDICAL and reinvest in areas with high investment efficiency after improving unit economics
Items this document does not state (12)
Selling, general and administrative expensesUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue declined due to restrained advertising investment by ONE MEDICAL. On the profit side, the increase was attributed to factors including higher profits from media services, the SaaS business turning profitable, reduced losses resulting from restrained advertising investment by ONE MEDICAL, higher non-operating income and lower tax expenses.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Briefing Materials for the Second Quarter of the Fiscal Year Ending March 2027 | Excite Holdings Co.,Ltd. (5571) timely disclosure | Komori